Recro Pharma, Inc. (NASDAQ:REPH) is reporting third quarter financial results on Monday 9th November 2020, before market open.
According to analysts surveyed by Thomson Reuters, REPH is expected to report 3Q20 loss of $ 0.2 per share from revenue of $ 16.33 million.
For the full year, analysts anticipate top line of $ 70.43 million, while looking forward to loss of $ 0.97 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 80.00 million ~ $ 85.00 million
Click Here For More Historical Outlooks Of Recro Pharma, Inc.
Previous Quarter Performance
Recro Pharma, Inc. announced loss for the second quarter of $ 0.25 per share, from the revenue of $ 15.52 million. The quarterly revenues contracted 50.35 percent compared with the same quarter last year. Street analysts expected Recro Pharma, Inc. to report loss of $ 0.16 per share on revenue of $ 18.88 million for the second quarter. The bottom line results missed street analysts by $ 0.09 or 56.25 percent, at the same time, top line results fell short of analysts by $ 3.36 million or 17.8 percent.
Stock Performance
On Friday, shares of Recro Pharma, Inc. has traded high as $ 1.64 and has cracked $ 1.56 on the downward trend, reaching $ 1.60 with volume of 225.80 thousand shares.
According to the previous trading day, closing price of $ 1.60, representing a 5.37 % increase from the 52 week low of $ 1.49 and a 91.83 % decrease over the 52 week high of $ 19.21.
The company has a market capital of $ 37.82 million and is part of the Healthcare sector and Biotechnology industry.
Conference Call
Recro Pharma, Inc. will be hosting a conference call at 8:00 AM eastern time on 9th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.recropharma.com
Recro Pharma, Inc. operates as a specialty pharmaceutical company. It operates through two divisions, an Acute Care, and Contract Development and Manufacturing (CDMO).
